SlideShare a Scribd company logo
1 of 5
Download to read offline
Journal of The Association of Physicians of India ■ Vol. 64 ■ November 2016 15
Hypomagnesemia in the ICU –
Does Correction Matter?
B Sheba Charles1
, Indira Menon2
, TS Girish3
, AM Cherian4
1
Post Graduate, 2
Consultant and Head of the ICU, 3
Consultant, 4
Professor and Head of the Dept. of General
Medicine, Bangalore Baptist Hospital, Bangalore, Karnataka
Received: 25.08.2015; Revised: 09.06.2016; Accepted: 08.08.2016
O r i g i n a l A r t i c l e
Abstract
Background: Magnesium is a cation that is constantly being rediscovered.
A number of studies have linked low magnesium levels to poor outcome of
critically ill patients. Despite this hypomagnesemia continues to be under-
recognized and uncorrected. There are no studies, in our knowledge, that
have assessed the impact of correction of hypomagnesaemia on the
outcome of the ICU patient. 
Aims and Objectives:
To determine the standard Mg levels in a healthy population sample and
to correlate it with western data. 
To estimate the admission Mg levels in critically ill patients admitted
to the ICU and to determine if routine correction of hypomagnesaemia
altered their outcomes as compared with the retrospectively collected
data of a similar group of patients admitted to the same ICU prior to the
routine testing of Mg levels.
This was an observational study carried out in the intensive care unit of
a tertiary hospital in south India 
Results: The mean serum magnesium in a sample of healthy Indian
population was noted to be 2.112 mg/dl, which is consistent with that
of the western data. Among the critically ill admitted to the medical ICU,
the incidence of Hypomagnesemia (defined as serum Mg+2
of ≤1.7mg/dl
on admission), was 23.96%. The study group in whom serum Magnesium
was routinely corrected, showed a decrease in the mean total duration of
icu stay (94.265 vs. 99.443 hours with p=0.78); the need for mechanical
ventilation (52.08% vs. 65.625%) and the duration of Mechanical
Ventilation (36.64 vs. 58.75 hours with p=0.04). Mortality was significantly
higher in the comparison group (p=0.01) (39.6% vs. 22.9%).
Conclusions: The range of Magnesium levels in a healthy Indian
population matches that of the west despite variations in diet and
lifestyle. Routine screening and replacement of magnesium in critically
ill patients with hypomagnesaemia resulted in reduction of morbidity
and statistically significant reduction in overall ICU mortality. 
metabolic acidosis, hypocalcemia
a n d h y p o m a g n e s e m i a e t c .
apart from many other nonfatal
complications which increase the
morbidity.1
Magnesium is also
used commonly in treatment of
hypertension in pregnancy, acute
asthma, muscle spasticity and
constipation. Yet, hypomagnesemia
often remains unrecognized in
the critically ill patients,3
 hence
magnesium has been called the
“forgotten cation.”4
 
Magnesium is the second-most
abundant intracellular cation
and, overall, the fourth-most
abundant. It plays a fundamental
role in many functions of the cell,
including energy transfer, storage
and metabolism; maintenance of
normal cell membrane function;
and the regulation of parathyroid
hormone secretion. Systemically,
m a g n e s i u m l o w e r s b l o o d
pressure and alters peripheral
Introduction
Hypomagnesemia can result
in well-known complications
like ventricular arrhythmias1,2
including Torsades de pointes,
widened QT interval,2
coronary
artery vasospasm, convulsions,
neuromuscular weakness, inability
to wean off the ventilator and several
metabolic abnormalities including
Editorial Viewpoint
•	 H y p o m a g n e s e m i a
continues to be under-
r e c o g n i z e d a n d
uncorrected.
•	 Thisstudyshowsincidence
of hypomagnesemia of
24% in critically ill.
•	 C o r r e c t i o n o f h y p o -
magnesemia reduces the
duration of ICU stay and
mechanical ventilation
and mortality as well.
Journal of The Association of Physicians of India ■ Vol. 64 ■ November 201616
vascular resistance. Magnesium is
involved in nearly every aspect of
biochemical metabolism, activates
almost all enzymes involved in
phosphorus reactions and acts as a
molecular stabilizer of ribonucleic
acids. Because it is bound to
adenosine triphosphate inside
the cell, shifts in it’s intracellular
c o n c e n t r a t i o n m a y h e l p t o
regulate cellular bioenergetics,
such as mitochondrial respiration.
Extracellularly, Mg+2
ions block
neurosynaptic transmission by
interfering with the release of
acetylcholine. Mg+2
ions also
may interfere with the release of
catecholamines from the adrenal
medulla and has been proposed
as an endogenous endocrine
modulator of the catecholamine
component of the physiologic stress
response.5
 
Methodology
A descriptive observational
study was carried out in two phases
in a tertiary care hospital in south
India, which provides service to a
population that is both urban and
rural, between Jan 2012 and Jun
2012. 
The initial phase estimated
the serum magnesium levels in a
sample of the normal population.
We randomly selected 50 hospital
job applicants and tested their
serum magnesium levels. All the
persons were >18years of age
and medically fit with no known
co-morbidities. The mean serum
magnesium of this group was
calculated.
The second phase was conducted
in the medical ICU where we
prospectively recruited 96 critically
ill patients into the study sample
from 6th
March 2012 to 5th
Jun 2012.
Critically ill patients who included
men and non-pregnant women
admitted in the MICU >18 years
with an APCHE II score > 10 were
included. Terminally ill patients,
those with end stage renal failure
with oliguria and non-medical
patients were excluded. The total
serum magnesium levels were
measured in all these patients
using the colorimetric method with
Xylidyl blue. Normal magnesium
levels were taken between 1.7mg/
dl –2.4mg/dl. 
The patients whose serum
magnesium levels were below
1.7mg/dl were identified and given
intravenous replacement therapy
as per the ICU protocol. The target
post correction serum Mg was 1.7
mg/dl. The study did not interfere
with the management of these
patients in the ICU. The correction
was done using I.V Magnesium
sulphate (8-32 milli equivalents as
infusion over 4-12 hours, depending
on the severity). Patients were
monitored throughout the infusion
for possible side effects like
sweating, flushing, bradycardia
and hypotension. The patient’s
vitals including the blood pressure,
pulse rate, respiratory rate, deep
tendon reflexes, mental status and
urine output were monitored and
serum Mg levels were monitored till
normal level was achieved to avoid
hypermagnesemia. Serum Mg levels
were not repeatedly checked once
the desired value was achieved post
correction. None of the patients
developed any side effects during
the magnesium infusion. The
outcomes documented in the study
group were: 
1.	 Duration of ICU stay 
2.	 Need for mechanical ventilator
support 
3.	 D u r a t i o n o f m e c h a n i c a l
ventilation 
4.	 Overall ICU mortality. 
This outcome data was compared
w i t h t h a t o f d a t a c o l l e c t e d
retrospectively from a comparison
group of 96 ICU patients, with
similar inclusion and exclusion
criteria who had been admitted
to the same facility prior to the
initiation of routine screening of
serum Magnesium levels (from
1st
Jan 2012 to 6th
March 2012). A
randomized controlled study was
not done as it would have been
unethical, given the evidence
regarding low Mg levels and poor
outcome. This can therefore be
considered a “before and after
study”. 
Statistical Analysis
Descriptive statistical analysis
was carried out for the study.
The study and the comparison
group were noted to be statistically
comparable with respect to the age
distribution with a p=0.061, sex
distribution with a p=0.104 and the
diagnostic frequency distribution
with a p=0.181 (Table 1). The average
APACHE score was also statistically
comparable (approximately 14.5 in
the control group versus 15.1 in
the study group). All the patients
included in the study had an
APACHE score of >10. Analysis
of variance (ANOVA) has been
used to find the significance of the
study parameters between the test
group and the comparison group.
Chi square test has been used to
find the significance of the study
parameters on categorical scale
between the two groups. All data
analysis was performed with a SPSS
statistical package (SPSS 16.0, SPSS
Inc. Chicago II. USA). Microsoft
word and Excel have been used to
generate graphics, tables etc.
Results
Estimation of Serum Magnesium
In Normal Population. The average
serum magnesium in the normal
population sample was noted to
be 2.112 mg/dl. The maximum
value noted was 2.6mg/dl and the
minimum was 1.8mg/dl. Our study
group consisted of predominantly
young females less than 35 years
of age belonging to middle class.
Hence age and sex related bias
may be expected. However even
in this small group, the serum
Mg+2
was noted to be within
the published normal range for
general population as mentioned
in all the previous studies; which
were mostly done on the Western
population whose diet and life
style vary significantly from that of
Indian population. Further studies
Journal of The Association of Physicians of India ■ Vol. 64 ■ November 2016 17
Table 1:	 Comparison of the two
groups with respect to age,
sex and diagnosis
Group Study
group
Control
group
Total
Age:
18-30 19 12 28
31-40 8 3 11
41-50 7 14 21
51-60 24 17 41
≥60 38 50 88
Total 96 96 189
Sex:
Male 64 53 117
Female 32 43 75
Total 96 96 192
Diagnostic frequency:
Cerebrovascular
accident
10 10 20
Acute coronary
event
8 10 18
Sepsis 21 23 44
Poisoning 11 7 18
Seizures 4 1 5
Acute on
chronic
respiratory dis.
10 9 19
Diabetic
ketoacidosis
0 1 1
Snake bite 6 0 6
Miscellaneous 26 35 61
Total 96 96 192
Apache score:
Average 14.5 15.1
with higher number of recruits with
a wider range of age group are
however necessary. There was no
significant difference in the serum
magnesium level between the
younger and the older age groups
as well as between the male and
female sex, in our study.
I n c i d e n c e o f l o w s e r u m
magnesium at admission to the
ICU: The average age of the patients
in the study group was 54±19.25
years with a maximum of 90 years
and a minimum of 18 years. (61/96)
63.54% were males. 36.46% (35/96)
were females. The average age
of the patients in the comparison
(control) group were 58.48±18.54
years with a maximum of 96 years
and a minimum was 19 years.
55.21% (53/96) were males and
44.79% (43/96) were females. The
frequency of different diagnoses
was found to be similar in both the
Table 2:	 Comparison of the outcomes between the study and control groups
Results of the present study Study group Control group Significance
Incidence of hypomagnesemia 23.96% Not known
Duration of ICU stay (hrs) 94.27 99.44 No (P=0.78)
Duration of mechanical ventilation (hrs) 36.64 58.75 Yes (P=0.04)
No. of cases ventilated 50 63 No (P=0.16)
Mortality rate 22.9% 39.6% Yes (P=0.01)
groups. The average APACHE score
was also statistically comparable
(14.5 in the control group versus
15.1 in the study group). The basic
characteristics of the study and the
control groups were statistically
comparable with respect to the age
distribution with a p=0.061 and
sex distribution with a p=0.104 as
well as the diagnostic frequency
distribution with a p=0.181. 
The serum magnesium level was
estimated in the study group and
the incidence of hypomagnesemia
(≤ 1.7mg/dl) was 23.95% (23/96).
The lowest serum Mg value
recorded was 0.9mg/dl while the
highest was 5mg/dl. The average
pre correction serum magnesium
in these hypomagnesemic patients
was 1.522 mg/dl. 16 patients
had a serum Mg ≥2.5mg/dl and
only one had >4mg/dl and none
above 5mg/dl. Normal and High
Magnesium were taken together
as a set in our study. Clinically
significant Hypermagnesemia is
>5 mg/dl3,4
according to various
studies done earlier. Studies show
that Hypermagnesemia4
which is
most of the time either iatrogenic
or secondary to renal failure;
is found less commonly than
hypomagnesaemia.
Comparison of parameters before
and after the routine screening and
correction of serum magnesium:
As shown in Table 2, the mean
duration of ICU stay in the in the
study group was 94.265 hours as
compared to 99.443 hours in the
comparison group. The duration
of ICU stay was relatively less (by
5.178 hours) in the study group.
(p = 0.78). The number of cases
requiring mechanical ventilation
in the study group was lower
than in the control group. Only
52.083% (n=50) required ventilator
support after routine magnesium
correction was initiated as against
65.625% (n=63) in the control
group (p=0.08). The duration
for mechanical ventilation was
36.64 hours in the study group as
compared to 58.75 hours in the
control group. The difference is
statistically significant (p=0.04).
The study group required 22.11
hours less duration of mechanical
ventilation (Table 1). The mortality
rate was 22% in the study group
where as it was 38% in the control
group; hence 16.7% lower after
routine screening and correction
of serum Mg+2
was introduced
in the ICU. This was statistically
significant with a p=0.01.
Comparison of parameters
“within” the study group – with
respect to serum magnesium:
The mean duration of ICU stay
(difference of 48.837 hours) (p=0.189)
as well as the Mean Duration of
Mechanical Ventilation (difference
of 13.667 hours) (p=0.349) were
found to be higher in patients
with low serum magnesium level
as compared with those with
normal serum magnesium (Table
3). Within the study group, total 50
out of the 96 required mechanical
ventilation. Of these, 15 had low
serum magnesium i.e, 30% of
the total of ventilated cases were
hypomagnesemic. 65% of the total
cases with hypomagnesemia in the
study group required ventilation
as compared to 47.94% of the cases
having normal levels of serum
magnesium (p=0.16). There was no
statistically significant difference
in the final mortality rate between
patients with hypomagnesemia
(21.73%) as compared to those
of normomagnesemia (23.28%).
This finding is very important to
be noted, as routine correction
Journal of The Association of Physicians of India ■ Vol. 64 ■ November 201618
done after screening in the study
group might have improved the
final mortality rate among the
hypomagnesemics. 
Discussion
How to Measure Hypomagnesemia
The method of measuring
Mg levels has been a subject
o f d e b a t e a s  r e s e a r c h e r s
f e e l t h a t m a g n e s i u m b e i n g
a predominantly  intracellular ion
, estimating total serum Mg levels
may not be accurate. Toffaletti6
in
1995, noted a substantial increase
in requests for serum Mg estimation
and the interest has only been
rising since then. Huijgen et al7
found that normal or high levels
of total magnesium were always
associated with normal ionized
Mg levels. However the positive
predictive value of a low total Mg
was only 29%. The RBC magnesium
and ionized Mg are considered
better measures of intracellular
Mg but they cannot be easily
estimated. Most studies still use
total serum Mg.5,8,9
On review of
literature, the “gold standard” for
establishing hypomagnesaemia is
probably the magnesium loading
test, where the level of absorption
of administered Mg indicates the
magnesium depletion in the body.
This test needs further evaluation
in the ICU patients. In our study
we measured total Magnesium in
the study group. 
Prevalence of Hypomagnesemia and
the Impact of routine Mg Replacement
T h e p r e v a l e n c e o f
hypomagnesemia in various
studies5
carried out in the critically
ill patients was in the range of
14-70%. In our study; 23% had
hypomagnesemia on admission
(defined as estimated total serum
Mg+2
of ≤1.7mg/dl). Studies that
measured ionized magnesium
reported lower prevalence of
hypomagnesaemia (Huijigen 14%
, Soliman 18%)7,9
than those that
had estimated total Mg or RBC Mg ,
where the prevalence was 20 -70% .
Hypermagnesemia has been
found to be less common10
and
ranges from 4% - 14%. Interestingly,
it has been associated with higher
mortality in some studies. We
found hypermagnesemia prevalent
in 17.7% patients but the levels
did not exceed the critical level of
5mg% and no change in clinical
outcome was noted. Hence these
patients have been taken into the
normomagnesemic group. 
On analyzing ‘within’ the study
group, hypomagnesemia cases were
noted to have higher mean duration
of total ICU stay (difference of
48.837 hours) (p=0.189) as well
as mean duration of Mechanical
Ve n t i l a t i o n ( d i f f e r e n c e o f
13.667 hours) (p=0.349). 65% of
hypomagnesemia cases in the study
group required ventilator support
as against 47.9% in those with
normal magnesium levels. Similar
findings were also documented in
another prospective observational
s t u d y d o n e b y C S L i m a y e
et al.5
Safavi et al8
described a
‘retrospective observational study’
which was done on 100 patients
≥16 years old, admitted to the ICU
at a University Hospital over 2
years period. Hypomagnesemic
patients were observed to have
higher APACHE II and SOFA scores
at admission (p < 0.01 for both),
a higher maximum SOFA score
during their ICU stay, a more need
to ventilator (p < 0.05), longer stay
in the ICU and longer duration of
mechanical ventilation (p < 0.01) as
well as higher mortality rate (55%
vs. 35%) when compared with the
normomagnesemic patients. 
In the current study, there was no
statistically significant difference
in the final mortality rate between
patients with hypomagnesemia
(21.73%) as compared to those
of normomagnesemia (23.28%)
‘ w i t h i n ’ t h e s t u d y g r o u p .
This is important to be noted
as a probable consequence of
routine correction of low serum
magnesium post admission. A
higher mortality rate8,9
can be
explained by greater incidence
of electrolyte abnormalities
especially hypokalemia11
and
cardiac arrhythmias2,12
and a strong
association with sepsis5
and septic
shock.
When these parameters were
compared before and after the
introduction of routine screening
and correction at admission to the
ICU, the total mean duration of
ICU stay was found to be relatively
less (by 5.177 hours) in the study
group, as compared to the control
group. However this was not
statistically significant (p=0.78).
But the mean difference of Duration
of Mechanical Ventilation in
MICU was statistically significant
(p=0.04). Post routine magnesium
correction, there was 22.11 hours
less requirement of mechanical
ventilation. The overall ICU
mortality was higher without
routine correction of serum
magnesium i.e, in the control group
(39.6%) as against 22.9% in the
study group and the difference was
noted to be statistically significant
(p=0.01).
Many factors contribute to
hypomagnesaemia in a patient
admitted to ICU like impaired GI
absorption, nasogastric suction,
poor content of Mg in the feeding
formulae or total parenteral
nutrition solutions, use of Proton
pump inhibitors routinely and
administration of drugs like
diuretics, amino glycosides,
Amphotericin B which cause
renal wasting.(11)
Even patients
with “normal” Magnesium at
admission level may even develop
low serum Mg after a few days of
ICU stay – hence we opine further
Table 3: 	 Comparison of the outcomes‘within’the study group – according to the
magnesium status
Magnesium status
(within the study group)
Duration of
stay (hours)
Duration of mechanical
ventilation (hours)
Need for mechanical
ventilation
Normal 82.57 33.37 35/73 (47.94%)
Low 131.40 47.03 15/23 (65.21%)
Journal of The Association of Physicians of India ■ Vol. 64 ■ November 2016 19
that routine screening of serum
magnesium should be done at least
intermittently during the stay in
ICU; not just at admission.
We also observed that 56.52% of
hypomagnesemics were Diabetics.
31.7% of Diabetics included in
the study group (70% in a study
by CS Limaye et al5
) had low
serum Mg. Hypomagnesemia has
been known to be associated with
Diabetes mellitus, due to increased
r e n a l l o s s e s o f m a g n e s i u m
that accompany glycosuria.11
Magnesium supplementation is
associated with decreased insulin
resistance.
30.43% of the hypomagnesemic
study subjects were noted to be
alcohol dependent and 43.7%
of the alcohol dependents had
hypomagnesemia. These findings
are comparable to all the earlier
studies.5,9
Chronic alcoholism is
one of the predisposing factors for
magnesium deficiency,11
reported
in 30% of hospital admissions
with alcohol abuse and in 85% of
admissions for delirium tremens.
This is due to a number of
factors including poor nutrition,
alcohol-induced renal tubular
dysfunction leading to renal
magnesium wasting, pancreatitis
and intracellular shift in alcohol
withdrawal syndrome.
Of all the complications of
low serum Mg+2
noted in this
study, generalized weakness,
gastrointestinal manifestations
of anorexia and vomiting were
p r e d o m i n a n t f o l l o w e d b y
neuromuscular manifestations i.e
muscle weakness and depression.
Metabolic abnormalities such as
hypocalcemia and hypokalemia
were also frequently associated. 
Conclusion
M a g n e s i u m r e m a i n s a n
important but often sidelined
cation in the critically ill patient.
Average serum Magnesium levels
in the Indian Population are similar
to that in the West. However
further studies with larger numbers
are required in this regard. Low
Mg levels on admission were
noted in 23% in our study group.
Correction of these levels improved
patient outcome by reducing the
length of ICU stay, the need and
duration of mechanical ventilation.
The overall ICU mortality reduction
was statistically significant.
T h e r e f o r e we r e c o m m e n d
routine screening at admission,
followed by regular monitoring
o f m a g n e s i u m l e v e l s , a s
hypomagnesaemia could develop
later too. We could not repeat the
serum magnesium repeatedly,
after initial correction, due to cost
constraints. The other limitations
of our study are the sample size,
and the optimization of the dose of
Magnesium supplementation. 
References
1.	 Bringhurst FR, Demay MB, Krane SM,
Kronenberg HM. Bone and Mineral
Metabolism in Health and Disease.
Harrison’s Principles of Internal Medicine,
(vol. 2 of 18th
edition, page 3089-3090).
2.	 K a g i m a , J a c q u e l i n e W a n j i k u :
Hypomagnesemia in critically ill patients
onadmissiontothecriticalcareunitsatthe
Kenyatta national hospital: A Prospective
Observational Cohort Study. Clinicalmed.
uonbi.ac.ke/node/897
3.	 Whang R, Ryder KW. Frequency of
hypomagnesemia and hypermagnesemia.
Requested vs. routine. JAMA 1990;
263:3063-4. 
4.	 Konrad M. Disorders of magnesium
metabolism. In: Geary D, Shaefer
F. Comprehensive Pediatric Nephrology.
Philadelphia PA: Mosby Elsevier; 2008:461-
475.
5.	 Limaye CS, Londhey VA, Nadkar MY,
Borges NE. Hypomagnesemia in critically
ill medical patients. J Assoc Physicians
India 2011; 59:19–22.
6.	 Toffaletti J. Physiology and regulation
ionized calcium, magnesium and lactate
measurements in critical care settings. Am
J Clin Pathol 1995; 104 (suppl1):S88-S94
7.	 Huijgen HJ, van Ingen HE, Sanders
R, et al. Precision of the magnesium
determination in mononuclear blood
cells and erythrocytes. Clin Biochem 1997;
30:203-208.
8.	 Safavi M, Honarmand A: Admission
hypomagnesemia- impact on mortality
and morbidity in critically ill patients.
MiddleEastJAnaesthesiol 2007; 19:645-60.
9.	 SolimanHM,MercanDetal:Development
of ionized hypomagnesemia is associated
with higher mortality rates. Crit Care Med
2003; 31:1082-7.
10.	 James W. Van Hook: Hypermagnesemia.
Critical Care Clinics 1991; 7:215-223.
11.	 Marino PL, Sutin KM. Fluid and Electrolyte
disorders – Magnesium. The ICU Book, 2nd
ed., Philadelphia, Lippincott, Williams and
Wilkins 2004; 660-672.
12.	 Khan AM, Lubitz SA, Sullivan LM, Sun JX,
Levy D, Vasan RS. Low serum magnesium
and the development of atrial fibrillation
in the community: the Framingham Heart
Study. Circulation 2013; 127:33-8.
Referees for JAPI
API Members with minimum ten years experience of clinical practice and who are interested to contribute for JAPI as Referee
may please send your details as listed below.
Name, Years of experience, Current designation and Affiliations, Area of interest, List of publications, e-mail id and Mobile
number.
Kindly send above information at the earliest to: onlinejapi@gmail.com
Prof. Milind Y. Nadkar
Editor-in-Chief, JAPI

More Related Content

What's hot

Nice Sugar Study - Glycemic control in the ICU
Nice Sugar Study - Glycemic control in the ICUNice Sugar Study - Glycemic control in the ICU
Nice Sugar Study - Glycemic control in the ICU
shivabirdi
 
Journal club vitamin c
Journal club vitamin c Journal club vitamin c
Journal club vitamin c
Yassin Alsaleh
 
Glycemic control in_the_icu
Glycemic control in_the_icuGlycemic control in_the_icu
Glycemic control in_the_icu
StevenP302
 
Guidelines for the use of an insulin infusion for the management of hyperglic...
Guidelines for the use of an insulin infusion for the management of hyperglic...Guidelines for the use of an insulin infusion for the management of hyperglic...
Guidelines for the use of an insulin infusion for the management of hyperglic...
Dr. Victor Euclides Briones Morales
 
Thyroid Abnormalities in Correlation with Stage of CKD in Tribal Population o...
Thyroid Abnormalities in Correlation with Stage of CKD in Tribal Population o...Thyroid Abnormalities in Correlation with Stage of CKD in Tribal Population o...
Thyroid Abnormalities in Correlation with Stage of CKD in Tribal Population o...
ijtsrd
 

What's hot (19)

Glycemic Control in Adult ICU
Glycemic Control in Adult ICUGlycemic Control in Adult ICU
Glycemic Control in Adult ICU
 
Strict Glycemic Control in Critically ill patients: The Demise of another ver...
Strict Glycemic Control in Critically ill patients: The Demise of another ver...Strict Glycemic Control in Critically ill patients: The Demise of another ver...
Strict Glycemic Control in Critically ill patients: The Demise of another ver...
 
A04120105
A04120105A04120105
A04120105
 
Journal club 20 10-2016
Journal club 20 10-2016Journal club 20 10-2016
Journal club 20 10-2016
 
Nice Sugar Study - Glycemic control in the ICU
Nice Sugar Study - Glycemic control in the ICUNice Sugar Study - Glycemic control in the ICU
Nice Sugar Study - Glycemic control in the ICU
 
ACCORD
ACCORDACCORD
ACCORD
 
Journal Club Presentation, JSSCP, MYSORE, INDIA.
Journal Club Presentation, JSSCP, MYSORE, INDIA.Journal Club Presentation, JSSCP, MYSORE, INDIA.
Journal Club Presentation, JSSCP, MYSORE, INDIA.
 
paper 4
paper 4paper 4
paper 4
 
The biomarker of choice in association of dyslipidemia with osteoporosis: A c...
The biomarker of choice in association of dyslipidemia with osteoporosis: A c...The biomarker of choice in association of dyslipidemia with osteoporosis: A c...
The biomarker of choice in association of dyslipidemia with osteoporosis: A c...
 
Gordon2017
Gordon2017Gordon2017
Gordon2017
 
Journal club vitamin c
Journal club vitamin c Journal club vitamin c
Journal club vitamin c
 
Moghissi
MoghissiMoghissi
Moghissi
 
Glycemic control in_the_icu
Glycemic control in_the_icuGlycemic control in_the_icu
Glycemic control in_the_icu
 
Journal club.ravi
Journal club.raviJournal club.ravi
Journal club.ravi
 
Guidelines for the use of an insulin infusion for the management of hyperglic...
Guidelines for the use of an insulin infusion for the management of hyperglic...Guidelines for the use of an insulin infusion for the management of hyperglic...
Guidelines for the use of an insulin infusion for the management of hyperglic...
 
Journal of Schizophrenia Research
Journal of Schizophrenia ResearchJournal of Schizophrenia Research
Journal of Schizophrenia Research
 
RABBIT 2
RABBIT 2RABBIT 2
RABBIT 2
 
Roux-en-Y gastric bypass vs intensive medical management for the control of t...
Roux-en-Y gastric bypass vs intensive medical management for the control of t...Roux-en-Y gastric bypass vs intensive medical management for the control of t...
Roux-en-Y gastric bypass vs intensive medical management for the control of t...
 
Thyroid Abnormalities in Correlation with Stage of CKD in Tribal Population o...
Thyroid Abnormalities in Correlation with Stage of CKD in Tribal Population o...Thyroid Abnormalities in Correlation with Stage of CKD in Tribal Population o...
Thyroid Abnormalities in Correlation with Stage of CKD in Tribal Population o...
 

Viewers also liked

Viewers also liked (7)

Cpc (2) (1)
Cpc (2) (1)Cpc (2) (1)
Cpc (2) (1)
 
Feros
FerosFeros
Feros
 
Hypertension and kidney (1)
Hypertension and kidney (1)Hypertension and kidney (1)
Hypertension and kidney (1)
 
Bmj.h5660.full
Bmj.h5660.fullBmj.h5660.full
Bmj.h5660.full
 
Sujay iyer beta blockers
Sujay iyer beta blockersSujay iyer beta blockers
Sujay iyer beta blockers
 
Sujay iyer beta blockers
Sujay iyer beta blockersSujay iyer beta blockers
Sujay iyer beta blockers
 
Bmj.h5660.full
Bmj.h5660.fullBmj.h5660.full
Bmj.h5660.full
 

Similar to 02 oa hypomagnesemia (1)

Serum magnesium level in esophageal and lung carcinoma patients
Serum magnesium level in esophageal and lung carcinoma patientsSerum magnesium level in esophageal and lung carcinoma patients
Serum magnesium level in esophageal and lung carcinoma patients
SSR Institute of International Journal of Life Sciences
 
IGNORANT THERAPEUTIC WAYS IN HEALTH SCIENCES
IGNORANT THERAPEUTIC WAYS IN HEALTH SCIENCESIGNORANT THERAPEUTIC WAYS IN HEALTH SCIENCES
IGNORANT THERAPEUTIC WAYS IN HEALTH SCIENCES
Dr Tarique Ahmed Maka
 
Thyroid dysfunction and insulin resistance journal ppt.pptx
Thyroid dysfunction and insulin resistance journal ppt.pptxThyroid dysfunction and insulin resistance journal ppt.pptx
Thyroid dysfunction and insulin resistance journal ppt.pptx
SyedFurqan30
 
(04) Effects of coenzyme Q10.pdf
(04) Effects of coenzyme Q10.pdf(04) Effects of coenzyme Q10.pdf
(04) Effects of coenzyme Q10.pdf
HLeyva1
 
Early Goal-Directed Therapy in Septic Shock
Early Goal-Directed Therapy in Septic ShockEarly Goal-Directed Therapy in Septic Shock
Early Goal-Directed Therapy in Septic Shock
shivabirdi
 
Predictors of Change in Adherence Status from 1 Year to the Next Among Patien...
Predictors of Change in Adherence Status from 1 Year to the Next Among Patien...Predictors of Change in Adherence Status from 1 Year to the Next Among Patien...
Predictors of Change in Adherence Status from 1 Year to the Next Among Patien...
Vishal Saundankar MS, PGDMM, BS (PHARMACY)
 
A study of modifiable and non-modifiable risk factors associated with diabeti...
A study of modifiable and non-modifiable risk factors associated with diabeti...A study of modifiable and non-modifiable risk factors associated with diabeti...
A study of modifiable and non-modifiable risk factors associated with diabeti...
International Journal of Medical Sciences and Nursing Research
 
Microalbuminuria in Saudi Adults with Type 1 Diabetes Mellitus_Crimson Publis...
Microalbuminuria in Saudi Adults with Type 1 Diabetes Mellitus_Crimson Publis...Microalbuminuria in Saudi Adults with Type 1 Diabetes Mellitus_Crimson Publis...
Microalbuminuria in Saudi Adults with Type 1 Diabetes Mellitus_Crimson Publis...
CrimsonPublishersIOD
 

Similar to 02 oa hypomagnesemia (1) (18)

Adopt
AdoptAdopt
Adopt
 
Anaemia in Chronic Renal Failure Patients Undergoing Haemodialysis: A across ...
Anaemia in Chronic Renal Failure Patients Undergoing Haemodialysis: A across ...Anaemia in Chronic Renal Failure Patients Undergoing Haemodialysis: A across ...
Anaemia in Chronic Renal Failure Patients Undergoing Haemodialysis: A across ...
 
Journal club
Journal clubJournal club
Journal club
 
Serum magnesium level in esophageal and lung carcinoma patients
Serum magnesium level in esophageal and lung carcinoma patientsSerum magnesium level in esophageal and lung carcinoma patients
Serum magnesium level in esophageal and lung carcinoma patients
 
IGNORANT THERAPEUTIC WAYS IN HEALTH SCIENCES
IGNORANT THERAPEUTIC WAYS IN HEALTH SCIENCESIGNORANT THERAPEUTIC WAYS IN HEALTH SCIENCES
IGNORANT THERAPEUTIC WAYS IN HEALTH SCIENCES
 
Thyroid dysfunction and insulin resistance journal ppt.pptx
Thyroid dysfunction and insulin resistance journal ppt.pptxThyroid dysfunction and insulin resistance journal ppt.pptx
Thyroid dysfunction and insulin resistance journal ppt.pptx
 
Conway2019
Conway2019Conway2019
Conway2019
 
Pharmacognosy of rice bran oil - A review
Pharmacognosy of rice bran oil - A reviewPharmacognosy of rice bran oil - A review
Pharmacognosy of rice bran oil - A review
 
Journal club solid organ transplant (New Onset Diabetes)
Journal club solid organ transplant (New Onset Diabetes)Journal club solid organ transplant (New Onset Diabetes)
Journal club solid organ transplant (New Onset Diabetes)
 
Tirzepatide versus Semiglutide Once Weekly in Patients with Type 2 Diabetes.pdf
Tirzepatide versus Semiglutide Once Weekly in Patients with Type 2 Diabetes.pdfTirzepatide versus Semiglutide Once Weekly in Patients with Type 2 Diabetes.pdf
Tirzepatide versus Semiglutide Once Weekly in Patients with Type 2 Diabetes.pdf
 
(04) Effects of coenzyme Q10.pdf
(04) Effects of coenzyme Q10.pdf(04) Effects of coenzyme Q10.pdf
(04) Effects of coenzyme Q10.pdf
 
Landmark trials in diabetes
Landmark trials in diabetesLandmark trials in diabetes
Landmark trials in diabetes
 
Cannabis medicinal
Cannabis medicinalCannabis medicinal
Cannabis medicinal
 
Landmark trial in lupus.pptx
Landmark trial in lupus.pptxLandmark trial in lupus.pptx
Landmark trial in lupus.pptx
 
Early Goal-Directed Therapy in Septic Shock
Early Goal-Directed Therapy in Septic ShockEarly Goal-Directed Therapy in Septic Shock
Early Goal-Directed Therapy in Septic Shock
 
Predictors of Change in Adherence Status from 1 Year to the Next Among Patien...
Predictors of Change in Adherence Status from 1 Year to the Next Among Patien...Predictors of Change in Adherence Status from 1 Year to the Next Among Patien...
Predictors of Change in Adherence Status from 1 Year to the Next Among Patien...
 
A study of modifiable and non-modifiable risk factors associated with diabeti...
A study of modifiable and non-modifiable risk factors associated with diabeti...A study of modifiable and non-modifiable risk factors associated with diabeti...
A study of modifiable and non-modifiable risk factors associated with diabeti...
 
Microalbuminuria in Saudi Adults with Type 1 Diabetes Mellitus_Crimson Publis...
Microalbuminuria in Saudi Adults with Type 1 Diabetes Mellitus_Crimson Publis...Microalbuminuria in Saudi Adults with Type 1 Diabetes Mellitus_Crimson Publis...
Microalbuminuria in Saudi Adults with Type 1 Diabetes Mellitus_Crimson Publis...
 

Recently uploaded

Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global Impact
PECB
 
Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdf
ciinovamais
 
Gardella_PRCampaignConclusion Pitch Letter
Gardella_PRCampaignConclusion Pitch LetterGardella_PRCampaignConclusion Pitch Letter
Gardella_PRCampaignConclusion Pitch Letter
MateoGardella
 

Recently uploaded (20)

Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activity
 
Unit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptxUnit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptx
 
Measures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SDMeasures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SD
 
SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...
SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...
SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...
 
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
 
Código Creativo y Arte de Software | Unidad 1
Código Creativo y Arte de Software | Unidad 1Código Creativo y Arte de Software | Unidad 1
Código Creativo y Arte de Software | Unidad 1
 
Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptx
 
psychiatric nursing HISTORY COLLECTION .docx
psychiatric  nursing HISTORY  COLLECTION  .docxpsychiatric  nursing HISTORY  COLLECTION  .docx
psychiatric nursing HISTORY COLLECTION .docx
 
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
 
Mattingly "AI & Prompt Design: The Basics of Prompt Design"
Mattingly "AI & Prompt Design: The Basics of Prompt Design"Mattingly "AI & Prompt Design: The Basics of Prompt Design"
Mattingly "AI & Prompt Design: The Basics of Prompt Design"
 
How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17
 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global Impact
 
Application orientated numerical on hev.ppt
Application orientated numerical on hev.pptApplication orientated numerical on hev.ppt
Application orientated numerical on hev.ppt
 
Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdf
 
Gardella_PRCampaignConclusion Pitch Letter
Gardella_PRCampaignConclusion Pitch LetterGardella_PRCampaignConclusion Pitch Letter
Gardella_PRCampaignConclusion Pitch Letter
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
 
Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024
 
Advance Mobile Application Development class 07
Advance Mobile Application Development class 07Advance Mobile Application Development class 07
Advance Mobile Application Development class 07
 
Introduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsIntroduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The Basics
 
Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17
 

02 oa hypomagnesemia (1)

  • 1. Journal of The Association of Physicians of India ■ Vol. 64 ■ November 2016 15 Hypomagnesemia in the ICU – Does Correction Matter? B Sheba Charles1 , Indira Menon2 , TS Girish3 , AM Cherian4 1 Post Graduate, 2 Consultant and Head of the ICU, 3 Consultant, 4 Professor and Head of the Dept. of General Medicine, Bangalore Baptist Hospital, Bangalore, Karnataka Received: 25.08.2015; Revised: 09.06.2016; Accepted: 08.08.2016 O r i g i n a l A r t i c l e Abstract Background: Magnesium is a cation that is constantly being rediscovered. A number of studies have linked low magnesium levels to poor outcome of critically ill patients. Despite this hypomagnesemia continues to be under- recognized and uncorrected. There are no studies, in our knowledge, that have assessed the impact of correction of hypomagnesaemia on the outcome of the ICU patient.  Aims and Objectives: To determine the standard Mg levels in a healthy population sample and to correlate it with western data.  To estimate the admission Mg levels in critically ill patients admitted to the ICU and to determine if routine correction of hypomagnesaemia altered their outcomes as compared with the retrospectively collected data of a similar group of patients admitted to the same ICU prior to the routine testing of Mg levels. This was an observational study carried out in the intensive care unit of a tertiary hospital in south India  Results: The mean serum magnesium in a sample of healthy Indian population was noted to be 2.112 mg/dl, which is consistent with that of the western data. Among the critically ill admitted to the medical ICU, the incidence of Hypomagnesemia (defined as serum Mg+2 of ≤1.7mg/dl on admission), was 23.96%. The study group in whom serum Magnesium was routinely corrected, showed a decrease in the mean total duration of icu stay (94.265 vs. 99.443 hours with p=0.78); the need for mechanical ventilation (52.08% vs. 65.625%) and the duration of Mechanical Ventilation (36.64 vs. 58.75 hours with p=0.04). Mortality was significantly higher in the comparison group (p=0.01) (39.6% vs. 22.9%). Conclusions: The range of Magnesium levels in a healthy Indian population matches that of the west despite variations in diet and lifestyle. Routine screening and replacement of magnesium in critically ill patients with hypomagnesaemia resulted in reduction of morbidity and statistically significant reduction in overall ICU mortality.  metabolic acidosis, hypocalcemia a n d h y p o m a g n e s e m i a e t c . apart from many other nonfatal complications which increase the morbidity.1 Magnesium is also used commonly in treatment of hypertension in pregnancy, acute asthma, muscle spasticity and constipation. Yet, hypomagnesemia often remains unrecognized in the critically ill patients,3  hence magnesium has been called the “forgotten cation.”4   Magnesium is the second-most abundant intracellular cation and, overall, the fourth-most abundant. It plays a fundamental role in many functions of the cell, including energy transfer, storage and metabolism; maintenance of normal cell membrane function; and the regulation of parathyroid hormone secretion. Systemically, m a g n e s i u m l o w e r s b l o o d pressure and alters peripheral Introduction Hypomagnesemia can result in well-known complications like ventricular arrhythmias1,2 including Torsades de pointes, widened QT interval,2 coronary artery vasospasm, convulsions, neuromuscular weakness, inability to wean off the ventilator and several metabolic abnormalities including Editorial Viewpoint • H y p o m a g n e s e m i a continues to be under- r e c o g n i z e d a n d uncorrected. • Thisstudyshowsincidence of hypomagnesemia of 24% in critically ill. • C o r r e c t i o n o f h y p o - magnesemia reduces the duration of ICU stay and mechanical ventilation and mortality as well.
  • 2. Journal of The Association of Physicians of India ■ Vol. 64 ■ November 201616 vascular resistance. Magnesium is involved in nearly every aspect of biochemical metabolism, activates almost all enzymes involved in phosphorus reactions and acts as a molecular stabilizer of ribonucleic acids. Because it is bound to adenosine triphosphate inside the cell, shifts in it’s intracellular c o n c e n t r a t i o n m a y h e l p t o regulate cellular bioenergetics, such as mitochondrial respiration. Extracellularly, Mg+2 ions block neurosynaptic transmission by interfering with the release of acetylcholine. Mg+2 ions also may interfere with the release of catecholamines from the adrenal medulla and has been proposed as an endogenous endocrine modulator of the catecholamine component of the physiologic stress response.5   Methodology A descriptive observational study was carried out in two phases in a tertiary care hospital in south India, which provides service to a population that is both urban and rural, between Jan 2012 and Jun 2012.  The initial phase estimated the serum magnesium levels in a sample of the normal population. We randomly selected 50 hospital job applicants and tested their serum magnesium levels. All the persons were >18years of age and medically fit with no known co-morbidities. The mean serum magnesium of this group was calculated. The second phase was conducted in the medical ICU where we prospectively recruited 96 critically ill patients into the study sample from 6th March 2012 to 5th Jun 2012. Critically ill patients who included men and non-pregnant women admitted in the MICU >18 years with an APCHE II score > 10 were included. Terminally ill patients, those with end stage renal failure with oliguria and non-medical patients were excluded. The total serum magnesium levels were measured in all these patients using the colorimetric method with Xylidyl blue. Normal magnesium levels were taken between 1.7mg/ dl –2.4mg/dl.  The patients whose serum magnesium levels were below 1.7mg/dl were identified and given intravenous replacement therapy as per the ICU protocol. The target post correction serum Mg was 1.7 mg/dl. The study did not interfere with the management of these patients in the ICU. The correction was done using I.V Magnesium sulphate (8-32 milli equivalents as infusion over 4-12 hours, depending on the severity). Patients were monitored throughout the infusion for possible side effects like sweating, flushing, bradycardia and hypotension. The patient’s vitals including the blood pressure, pulse rate, respiratory rate, deep tendon reflexes, mental status and urine output were monitored and serum Mg levels were monitored till normal level was achieved to avoid hypermagnesemia. Serum Mg levels were not repeatedly checked once the desired value was achieved post correction. None of the patients developed any side effects during the magnesium infusion. The outcomes documented in the study group were:  1. Duration of ICU stay  2. Need for mechanical ventilator support  3. D u r a t i o n o f m e c h a n i c a l ventilation  4. Overall ICU mortality.  This outcome data was compared w i t h t h a t o f d a t a c o l l e c t e d retrospectively from a comparison group of 96 ICU patients, with similar inclusion and exclusion criteria who had been admitted to the same facility prior to the initiation of routine screening of serum Magnesium levels (from 1st Jan 2012 to 6th March 2012). A randomized controlled study was not done as it would have been unethical, given the evidence regarding low Mg levels and poor outcome. This can therefore be considered a “before and after study”.  Statistical Analysis Descriptive statistical analysis was carried out for the study. The study and the comparison group were noted to be statistically comparable with respect to the age distribution with a p=0.061, sex distribution with a p=0.104 and the diagnostic frequency distribution with a p=0.181 (Table 1). The average APACHE score was also statistically comparable (approximately 14.5 in the control group versus 15.1 in the study group). All the patients included in the study had an APACHE score of >10. Analysis of variance (ANOVA) has been used to find the significance of the study parameters between the test group and the comparison group. Chi square test has been used to find the significance of the study parameters on categorical scale between the two groups. All data analysis was performed with a SPSS statistical package (SPSS 16.0, SPSS Inc. Chicago II. USA). Microsoft word and Excel have been used to generate graphics, tables etc. Results Estimation of Serum Magnesium In Normal Population. The average serum magnesium in the normal population sample was noted to be 2.112 mg/dl. The maximum value noted was 2.6mg/dl and the minimum was 1.8mg/dl. Our study group consisted of predominantly young females less than 35 years of age belonging to middle class. Hence age and sex related bias may be expected. However even in this small group, the serum Mg+2 was noted to be within the published normal range for general population as mentioned in all the previous studies; which were mostly done on the Western population whose diet and life style vary significantly from that of Indian population. Further studies
  • 3. Journal of The Association of Physicians of India ■ Vol. 64 ■ November 2016 17 Table 1: Comparison of the two groups with respect to age, sex and diagnosis Group Study group Control group Total Age: 18-30 19 12 28 31-40 8 3 11 41-50 7 14 21 51-60 24 17 41 ≥60 38 50 88 Total 96 96 189 Sex: Male 64 53 117 Female 32 43 75 Total 96 96 192 Diagnostic frequency: Cerebrovascular accident 10 10 20 Acute coronary event 8 10 18 Sepsis 21 23 44 Poisoning 11 7 18 Seizures 4 1 5 Acute on chronic respiratory dis. 10 9 19 Diabetic ketoacidosis 0 1 1 Snake bite 6 0 6 Miscellaneous 26 35 61 Total 96 96 192 Apache score: Average 14.5 15.1 with higher number of recruits with a wider range of age group are however necessary. There was no significant difference in the serum magnesium level between the younger and the older age groups as well as between the male and female sex, in our study. I n c i d e n c e o f l o w s e r u m magnesium at admission to the ICU: The average age of the patients in the study group was 54±19.25 years with a maximum of 90 years and a minimum of 18 years. (61/96) 63.54% were males. 36.46% (35/96) were females. The average age of the patients in the comparison (control) group were 58.48±18.54 years with a maximum of 96 years and a minimum was 19 years. 55.21% (53/96) were males and 44.79% (43/96) were females. The frequency of different diagnoses was found to be similar in both the Table 2: Comparison of the outcomes between the study and control groups Results of the present study Study group Control group Significance Incidence of hypomagnesemia 23.96% Not known Duration of ICU stay (hrs) 94.27 99.44 No (P=0.78) Duration of mechanical ventilation (hrs) 36.64 58.75 Yes (P=0.04) No. of cases ventilated 50 63 No (P=0.16) Mortality rate 22.9% 39.6% Yes (P=0.01) groups. The average APACHE score was also statistically comparable (14.5 in the control group versus 15.1 in the study group). The basic characteristics of the study and the control groups were statistically comparable with respect to the age distribution with a p=0.061 and sex distribution with a p=0.104 as well as the diagnostic frequency distribution with a p=0.181.  The serum magnesium level was estimated in the study group and the incidence of hypomagnesemia (≤ 1.7mg/dl) was 23.95% (23/96). The lowest serum Mg value recorded was 0.9mg/dl while the highest was 5mg/dl. The average pre correction serum magnesium in these hypomagnesemic patients was 1.522 mg/dl. 16 patients had a serum Mg ≥2.5mg/dl and only one had >4mg/dl and none above 5mg/dl. Normal and High Magnesium were taken together as a set in our study. Clinically significant Hypermagnesemia is >5 mg/dl3,4 according to various studies done earlier. Studies show that Hypermagnesemia4 which is most of the time either iatrogenic or secondary to renal failure; is found less commonly than hypomagnesaemia. Comparison of parameters before and after the routine screening and correction of serum magnesium: As shown in Table 2, the mean duration of ICU stay in the in the study group was 94.265 hours as compared to 99.443 hours in the comparison group. The duration of ICU stay was relatively less (by 5.178 hours) in the study group. (p = 0.78). The number of cases requiring mechanical ventilation in the study group was lower than in the control group. Only 52.083% (n=50) required ventilator support after routine magnesium correction was initiated as against 65.625% (n=63) in the control group (p=0.08). The duration for mechanical ventilation was 36.64 hours in the study group as compared to 58.75 hours in the control group. The difference is statistically significant (p=0.04). The study group required 22.11 hours less duration of mechanical ventilation (Table 1). The mortality rate was 22% in the study group where as it was 38% in the control group; hence 16.7% lower after routine screening and correction of serum Mg+2 was introduced in the ICU. This was statistically significant with a p=0.01. Comparison of parameters “within” the study group – with respect to serum magnesium: The mean duration of ICU stay (difference of 48.837 hours) (p=0.189) as well as the Mean Duration of Mechanical Ventilation (difference of 13.667 hours) (p=0.349) were found to be higher in patients with low serum magnesium level as compared with those with normal serum magnesium (Table 3). Within the study group, total 50 out of the 96 required mechanical ventilation. Of these, 15 had low serum magnesium i.e, 30% of the total of ventilated cases were hypomagnesemic. 65% of the total cases with hypomagnesemia in the study group required ventilation as compared to 47.94% of the cases having normal levels of serum magnesium (p=0.16). There was no statistically significant difference in the final mortality rate between patients with hypomagnesemia (21.73%) as compared to those of normomagnesemia (23.28%). This finding is very important to be noted, as routine correction
  • 4. Journal of The Association of Physicians of India ■ Vol. 64 ■ November 201618 done after screening in the study group might have improved the final mortality rate among the hypomagnesemics.  Discussion How to Measure Hypomagnesemia The method of measuring Mg levels has been a subject o f d e b a t e a s  r e s e a r c h e r s f e e l t h a t m a g n e s i u m b e i n g a predominantly  intracellular ion , estimating total serum Mg levels may not be accurate. Toffaletti6 in 1995, noted a substantial increase in requests for serum Mg estimation and the interest has only been rising since then. Huijgen et al7 found that normal or high levels of total magnesium were always associated with normal ionized Mg levels. However the positive predictive value of a low total Mg was only 29%. The RBC magnesium and ionized Mg are considered better measures of intracellular Mg but they cannot be easily estimated. Most studies still use total serum Mg.5,8,9 On review of literature, the “gold standard” for establishing hypomagnesaemia is probably the magnesium loading test, where the level of absorption of administered Mg indicates the magnesium depletion in the body. This test needs further evaluation in the ICU patients. In our study we measured total Magnesium in the study group.  Prevalence of Hypomagnesemia and the Impact of routine Mg Replacement T h e p r e v a l e n c e o f hypomagnesemia in various studies5 carried out in the critically ill patients was in the range of 14-70%. In our study; 23% had hypomagnesemia on admission (defined as estimated total serum Mg+2 of ≤1.7mg/dl). Studies that measured ionized magnesium reported lower prevalence of hypomagnesaemia (Huijigen 14% , Soliman 18%)7,9 than those that had estimated total Mg or RBC Mg , where the prevalence was 20 -70% . Hypermagnesemia has been found to be less common10 and ranges from 4% - 14%. Interestingly, it has been associated with higher mortality in some studies. We found hypermagnesemia prevalent in 17.7% patients but the levels did not exceed the critical level of 5mg% and no change in clinical outcome was noted. Hence these patients have been taken into the normomagnesemic group.  On analyzing ‘within’ the study group, hypomagnesemia cases were noted to have higher mean duration of total ICU stay (difference of 48.837 hours) (p=0.189) as well as mean duration of Mechanical Ve n t i l a t i o n ( d i f f e r e n c e o f 13.667 hours) (p=0.349). 65% of hypomagnesemia cases in the study group required ventilator support as against 47.9% in those with normal magnesium levels. Similar findings were also documented in another prospective observational s t u d y d o n e b y C S L i m a y e et al.5 Safavi et al8 described a ‘retrospective observational study’ which was done on 100 patients ≥16 years old, admitted to the ICU at a University Hospital over 2 years period. Hypomagnesemic patients were observed to have higher APACHE II and SOFA scores at admission (p < 0.01 for both), a higher maximum SOFA score during their ICU stay, a more need to ventilator (p < 0.05), longer stay in the ICU and longer duration of mechanical ventilation (p < 0.01) as well as higher mortality rate (55% vs. 35%) when compared with the normomagnesemic patients.  In the current study, there was no statistically significant difference in the final mortality rate between patients with hypomagnesemia (21.73%) as compared to those of normomagnesemia (23.28%) ‘ w i t h i n ’ t h e s t u d y g r o u p . This is important to be noted as a probable consequence of routine correction of low serum magnesium post admission. A higher mortality rate8,9 can be explained by greater incidence of electrolyte abnormalities especially hypokalemia11 and cardiac arrhythmias2,12 and a strong association with sepsis5 and septic shock. When these parameters were compared before and after the introduction of routine screening and correction at admission to the ICU, the total mean duration of ICU stay was found to be relatively less (by 5.177 hours) in the study group, as compared to the control group. However this was not statistically significant (p=0.78). But the mean difference of Duration of Mechanical Ventilation in MICU was statistically significant (p=0.04). Post routine magnesium correction, there was 22.11 hours less requirement of mechanical ventilation. The overall ICU mortality was higher without routine correction of serum magnesium i.e, in the control group (39.6%) as against 22.9% in the study group and the difference was noted to be statistically significant (p=0.01). Many factors contribute to hypomagnesaemia in a patient admitted to ICU like impaired GI absorption, nasogastric suction, poor content of Mg in the feeding formulae or total parenteral nutrition solutions, use of Proton pump inhibitors routinely and administration of drugs like diuretics, amino glycosides, Amphotericin B which cause renal wasting.(11) Even patients with “normal” Magnesium at admission level may even develop low serum Mg after a few days of ICU stay – hence we opine further Table 3: Comparison of the outcomes‘within’the study group – according to the magnesium status Magnesium status (within the study group) Duration of stay (hours) Duration of mechanical ventilation (hours) Need for mechanical ventilation Normal 82.57 33.37 35/73 (47.94%) Low 131.40 47.03 15/23 (65.21%)
  • 5. Journal of The Association of Physicians of India ■ Vol. 64 ■ November 2016 19 that routine screening of serum magnesium should be done at least intermittently during the stay in ICU; not just at admission. We also observed that 56.52% of hypomagnesemics were Diabetics. 31.7% of Diabetics included in the study group (70% in a study by CS Limaye et al5 ) had low serum Mg. Hypomagnesemia has been known to be associated with Diabetes mellitus, due to increased r e n a l l o s s e s o f m a g n e s i u m that accompany glycosuria.11 Magnesium supplementation is associated with decreased insulin resistance. 30.43% of the hypomagnesemic study subjects were noted to be alcohol dependent and 43.7% of the alcohol dependents had hypomagnesemia. These findings are comparable to all the earlier studies.5,9 Chronic alcoholism is one of the predisposing factors for magnesium deficiency,11 reported in 30% of hospital admissions with alcohol abuse and in 85% of admissions for delirium tremens. This is due to a number of factors including poor nutrition, alcohol-induced renal tubular dysfunction leading to renal magnesium wasting, pancreatitis and intracellular shift in alcohol withdrawal syndrome. Of all the complications of low serum Mg+2 noted in this study, generalized weakness, gastrointestinal manifestations of anorexia and vomiting were p r e d o m i n a n t f o l l o w e d b y neuromuscular manifestations i.e muscle weakness and depression. Metabolic abnormalities such as hypocalcemia and hypokalemia were also frequently associated.  Conclusion M a g n e s i u m r e m a i n s a n important but often sidelined cation in the critically ill patient. Average serum Magnesium levels in the Indian Population are similar to that in the West. However further studies with larger numbers are required in this regard. Low Mg levels on admission were noted in 23% in our study group. Correction of these levels improved patient outcome by reducing the length of ICU stay, the need and duration of mechanical ventilation. The overall ICU mortality reduction was statistically significant. T h e r e f o r e we r e c o m m e n d routine screening at admission, followed by regular monitoring o f m a g n e s i u m l e v e l s , a s hypomagnesaemia could develop later too. We could not repeat the serum magnesium repeatedly, after initial correction, due to cost constraints. The other limitations of our study are the sample size, and the optimization of the dose of Magnesium supplementation.  References 1. Bringhurst FR, Demay MB, Krane SM, Kronenberg HM. Bone and Mineral Metabolism in Health and Disease. Harrison’s Principles of Internal Medicine, (vol. 2 of 18th edition, page 3089-3090). 2. K a g i m a , J a c q u e l i n e W a n j i k u : Hypomagnesemia in critically ill patients onadmissiontothecriticalcareunitsatthe Kenyatta national hospital: A Prospective Observational Cohort Study. Clinicalmed. uonbi.ac.ke/node/897 3. Whang R, Ryder KW. Frequency of hypomagnesemia and hypermagnesemia. Requested vs. routine. JAMA 1990; 263:3063-4.  4. Konrad M. Disorders of magnesium metabolism. In: Geary D, Shaefer F. Comprehensive Pediatric Nephrology. Philadelphia PA: Mosby Elsevier; 2008:461- 475. 5. Limaye CS, Londhey VA, Nadkar MY, Borges NE. Hypomagnesemia in critically ill medical patients. J Assoc Physicians India 2011; 59:19–22. 6. Toffaletti J. Physiology and regulation ionized calcium, magnesium and lactate measurements in critical care settings. Am J Clin Pathol 1995; 104 (suppl1):S88-S94 7. Huijgen HJ, van Ingen HE, Sanders R, et al. Precision of the magnesium determination in mononuclear blood cells and erythrocytes. Clin Biochem 1997; 30:203-208. 8. Safavi M, Honarmand A: Admission hypomagnesemia- impact on mortality and morbidity in critically ill patients. MiddleEastJAnaesthesiol 2007; 19:645-60. 9. SolimanHM,MercanDetal:Development of ionized hypomagnesemia is associated with higher mortality rates. Crit Care Med 2003; 31:1082-7. 10. James W. Van Hook: Hypermagnesemia. Critical Care Clinics 1991; 7:215-223. 11. Marino PL, Sutin KM. Fluid and Electrolyte disorders – Magnesium. The ICU Book, 2nd ed., Philadelphia, Lippincott, Williams and Wilkins 2004; 660-672. 12. Khan AM, Lubitz SA, Sullivan LM, Sun JX, Levy D, Vasan RS. Low serum magnesium and the development of atrial fibrillation in the community: the Framingham Heart Study. Circulation 2013; 127:33-8. Referees for JAPI API Members with minimum ten years experience of clinical practice and who are interested to contribute for JAPI as Referee may please send your details as listed below. Name, Years of experience, Current designation and Affiliations, Area of interest, List of publications, e-mail id and Mobile number. Kindly send above information at the earliest to: onlinejapi@gmail.com Prof. Milind Y. Nadkar Editor-in-Chief, JAPI